The new approach to assignment of ASFA categories - Introduction to the fourth special issue: Clinical applications of therapeutic apheresis

被引:62
作者
Szczepiorkowski, Zbigniew M.
Shaz, Beth H.
Bandarenko, Nicholas
Winters, Jeffrey L.
机构
[1] Dartmouth Coll, Hitchcock Med Ctr, Transfus Med Serv, Dept Pathol, Lebanon, NH 03756 USA
[2] Emory Univ, Grady Mem Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[3] Univ N Carolina Hosp, Dept Pathol & Lab Med, Chapel Hill, NC USA
[4] Mayo Clin, Div Transfus Med, Rochester, MN USA
关键词
apheresis; plasma exchange; immunoadsorption; leukocytapheresis; photopheresis; categories;
D O I
10.1002/jca.20134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Society for Apheresis (ASFA) Apheresis Applications Committee is responsible for a review and categorization of indications for therapeutic apheresis. The results of the review process were previously published in 1986, 1993, and 2000 as the ASFA Special Issues. The ASFA categories consist of categories I through IV, and category P (pending). This article describes the novel methodology, based on structured systematic review of the published literature, used to assign categories for indications for therapeutic apheresis. This is the first time each entity is presented as a fact sheet, which summarizes the evidence for the use of therapeutic apheresis. A detailed description of the fact sheet format and the individual fact sheets for categories I through III and category P are presented in the main article of this Special Issue. The diseases assigned to category IV are discussed in a separate article in this issue. Information on how the Apheresis Applications Committee proposes to include new diseases for category assignment is also provided.
引用
收藏
页码:96 / 105
页数:10
相关论文
共 11 条
[1]   Systems for grading the quality of evidence and the strength of recommendations -: I:: Critical appraisal of existing approaches The GRADE Working Group -: art. no. 38 [J].
Atkins, D ;
Eccles, M ;
Flottorp, S ;
Guyatt, GH ;
Henry, D ;
Hill, S ;
Liberati, A ;
O'Connell, D ;
Oxman, AD ;
Phillips, B ;
Schünemann, H ;
Edejer, TTT ;
Vist, GE ;
Williams, JW .
BMC HEALTH SERVICES RESEARCH, 2004, 4 (1)
[2]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[3]   An approach to evidence-based therapeutic apheresis [J].
McLeod, BC .
JOURNAL OF CLINICAL APHERESIS, 2002, 17 (03) :124-132
[4]  
McLeod BC, 2000, J CLIN APHERESIS, V15, P1
[5]  
MCLEOD BC, 2003, PAHERESIS PRINCIPLES
[6]  
McLeod BC, 2005, THERAPEUTIC APHERESI
[7]   Category IV indications for therapeutic apheresis - ASFA fourth special issue [J].
Shaz, Beth H. ;
Linenberger, Michael L. ;
Bandarenko, Nicholas ;
Winters, Jeffrey L. ;
Kim, Haewon C. ;
Marques, Marisa B. ;
Sarode, Ravindra ;
Schwartz, Joseph ;
Weinstein, Robert ;
Wirk, Ashka ;
Szczepiorkowski, Zbigniew M. .
JOURNAL OF CLINICAL APHERESIS, 2007, 22 (03) :176-180
[8]   Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis [J].
Szczepiorkowski, Zbigniew M. ;
Bandarenko, Nicholas ;
Kim, Haewon C. ;
Linenberger, Michael L. ;
Marques, Marisa B. ;
Sarode, Ravindra ;
Schwartz, Joseph ;
Shaz, Beth H. ;
Weinstein, Robert ;
Wirk, Ashka ;
Winters, Jeffrey L. .
JOURNAL OF CLINICAL APHERESIS, 2007, 22 (03) :106-175
[9]  
*U HLTH SYST CONS, 1999, TECHN ASS INTR IMM P
[10]  
Vamvakas EC, 2000, J CLIN APHERESIS, V15, P6, DOI 10.1002/(SICI)1098-1101(2000)15:1/2<6::AID-JCA2>3.0.CO